INTRODUCTION
============

Free muscle flaps are a workhorse for reconstruction of lower extremity wounds. Established indications include distal third wounds and large defects with exposed bone, tendon or other vital structures. There remains a preference among many orthopedic surgeons, for muscle flap coverage, in the belief that this has a beneficial effect on decreasing infection rates \[[@b1-aps-2016-01977]\]. The increased capacity of muscle compared to fasciocutaneous flaps for inhibiting bacterial growth has been shown in animal studies \[[@b2-aps-2016-01977]-[@b4-aps-2016-01977]\]. However, the published literature has not shown a difference between free muscle and free fasciocutaneous flaps for lower extremity coverage \[[@b5-aps-2016-01977],[@b6-aps-2016-01977]\].

A major problem with free muscle flaps in the lower extremity is postoperative swelling. This necessitates a "dangle protocol" to allow the free muscle to get used to the increased effect of gravity. Nevertheless, the swelling in the free muscle can take many months to resolve, and may never approach the contour and thickness of normal skin in the lower extremity. The muscle edema can also prolong the healing course, leading to problems such as loss of skin graft.

A solution used by the senior author and some other surgeons is immediate application of a vacuum assisted closure (VAC) dressing after free muscle coverage of the lower extremity. The VAC dressing has been shown to optimize blood flow, decrease local tissue edema and remove excess fluid from the wound bed \[[@b7-aps-2016-01977]\]. In this fashion, the free muscle flap does not increase in thickness postoperatively, preventing the swelling normally seen following microsurgical transfer to the lower extremity. Another advantage of the VAC dressing is that regular irrigation of the flap to prevent desiccation is not required. The VAC dressing also has been shown to encourage take and survival of skin grafts over the free muscle flap \[[@b8-aps-2016-01977]\]. Flap monitoring relies entirely on the Cook-Swartz implantable Doppler device (Cook Medical, Bloomington, IN, USA).

A criticism of this approach is that there is no way to monitor the flap using traditional techniques, such as visual observation and transcutaneous Doppler signals. While the benefits of a VAC dressing are not in question, flap monitoring is the main concern that prevents widespread adoption of this technique.

The aim of this study was to prospectively compare flap outcomes and flap thickness in a level I trauma center between consecutive patients who had immediate postoperative application of a VAC dressing following free muscle flap coverage of lower extremity wounds and patients who had the muscle exposed for monitoring.

METHODS
=======

A prospective study was performed in a level I trauma center for all patients who underwent free muscle flap coverage for leg wounds distal to the knee. This was performed over a 19 months period from December 2014 to June 2016 involving all consecutive patients, with at least 2 months follow-up postoperatively for all patients. The institutional review board approved the study and patients gave verbal informed consent for flap measurements. The senior author performed immediate application of a VAC dressing following free muscle coverage of lower extremity wounds (Group 1), while the other microsurgeons in the institution left the flap exposed for monitoring, with wet to dry dressings and regular saline irrigation (Group 2). The VAC was set on 75 mm Hg on continuous suction. The VAC dressing when used was removed on postoperative day 5. There were 9 free muscle flaps performed in Group 1 and 8 in Group 2, for a total of 17 consecutive flaps. A standard postoperative dangle protocol was followed, with progressive dangling commenced at postoperative day 14.

Outcomes inclusive of flap survival and complications were recorded, in addition to demographic data. Flap thickness, defined as the distance between the highest point of the flap and the adjacent skin was measured ([Fig. 1](#f1-aps-2016-01977){ref-type="fig"}) at regular intervals on postoperative day 5 and when the patient presented to the outpatient clinic for short and long-term follow-up. Long-term follow-up was not available for all patients. The majority of patients were treated at a county hospital, with many homeless, uninsured or from out of state. Hence many were not willing to return for follow-up flap measurements. Statistical analysis was performed using the student's t-test or chi square test to compare flap thickness and other variables between groups.

RESULTS
=======

Patient data is presented in [Table 1](#t1-aps-2016-01977){ref-type="table"}. Mean age of patients in Group 1 was 40.6±16.1 years, while in Group 2 mean age was 35.1±16.0. There was no significant difference in age or body mass index between groups. All patients had Gustilo IIIB open tibial fractures of the leg that required coverage except for 3 patients with other pathology involving the foot and heel in Group 1 and 1 patient with chronic osteomyelitis of the tibia in Group 2. Flap outcome data is shown in [Table 2](#t2-aps-2016-01977){ref-type="table"}. There was no statistically significant difference in flap survival between both groups. Flap thickness was measured on postoperative day 5 in all patients. Mean flap thickness at postoperative day 5 for the VAC group was 6.4±6.4 mm, while flap thickness for the exposed flap group was 29.6±13.5 mm. There was a statistically significant difference (P\<0.05) in flap thickness between patients treated with a VAC dressing and those where the flap was left exposed for monitoring. [Figs. 2](#f2-aps-2016-01977){ref-type="fig"} and [3](#f3-aps-2016-01977){ref-type="fig"} illustrate the difference in flap thickness and decreased swelling seen with free muscle flaps treated with an immediate VAC dressing compared to those left open to air for monitoring. [Fig. 4](#f4-aps-2016-01977){ref-type="fig"} shows the natural evolution of a flap for coverage for distal third leg wound treated with immediate application of the VAC. Postoperative flap swelling encountered routinely with muscle flaps was not seen. The thickness of the flap remained similar on short and long-term follow-up.

In the VAC dressing group (Group 1), there was 1 flap failure due to previously undiagnosed deep vein thrombosis (diagnosed after the flap was performed) involving the entire deep venous system of the affected lower extremity from the pelvis to the crural veins, leading to venous outflow obstruction. This resulted in delayed flap failure from venous congestion after 2 weeks. The wound was treated with Integra (Integra Lifesciences) and subsequently skin grafted, with successful limb salvage. In Group 2, there were 2 flap failures. One patient had flap loss due to arterial thrombosis and was treated with a repeat muscle flap to a different recipient artery on postoperative day 7, with successful limb salvage. The other patient had flap loss due to persistent unresolved infection from antibiotic resistant Pseudomonas Aeruginosa, which resulted in a below knee amputation. No other flaps required flap exploration nor were otherwise compromised in the postoperative period.

DISCUSSION
==========

The VAC dressing has the advantage of reducing edema of the flap in the short term. In the senior author's limited experience, this also translates to earlier resolution of edema, which is a persistent problem with free muscle flaps to the lower extremity, that can take up to 1 year to resolve. Other mechanisms of action of the VAC dressing include optimizing blood flow and removal of excess fluid from the wound bed, though these are probably less important in this application. The reduction of edema through the VAC dressing most likely occurs through microdeformation of the local wound environment by the VAC sponge allowing excess interstitial fluid to be removed from the muscle flap as well as macrodeformation which allows the VAC sponge itself to act as a splint to exert a limited amount of compression over the flap to reduce the development of edema in the immediate postoperative period.

In addition, by reducing the amount of swelling in the immediate postoperative period, the VAC dressing prevents a wrinkled appearance of the flap in the long-term following atrophy of the muscle, which results when a very swollen flap atrophies and leaves an excess skin grafted surface. Without the VAC dressing, we have found that flap revision is often necessary, due to patient requests to reduce the thickness of the flap and remove excess tissue. For reconstruction in the foot, this is particularly a problem, as patients often have problems fitting adequate footwear due to thickness of the flap. With immediate application of the VAC, we have found that these problems are to a certain extent, ameliorated.

A limitation of this study is the small sample size in each cohort. However, with the increasing use of propeller and perforator based flaps and free fasciocutaneous flaps for reconstruction of distal third lower extremity wounds, it is difficult for any one center to accumulate a large number of patients requiring free muscle flaps for lower extremity reconstruction. This is true in our center, where the number of patients requiring a free muscle flap has decreased dramatically due to other available options for reconstruction. In addition a true prospective randomized trial examining the efficacy of the VAC dressing will probably be impossible to perform, because each surgeon will have his or her own preconceptions about the safety of immediate VAC dressing over free muscle flaps and flap monitoring, and will be unlikely to compromise these beliefs in a complex and high risk procedure like a free flap. Another limitation of the study is the short-term follow-up measurement of flap thickness in some patients. However, due to the nature of the patient population that sustains these types of injuries in our cohort, long-term follow-up was not possible in many patients. Finally three patients in the group without VAC dressing had a rectus muscle flap, which is often thicker than the latissimus, or serratus muscle flaps. However, patients who had latissimus flaps in the group without VAC dressing also had noticeably increased flap thickness.

Nevertheless, this prospective study represents the only published evidence in the literature, to our knowledge, about the efficacy and safety of the VAC dressing for immediate application following lower extremity free muscle flaps. Our data supports the immediate application of VAC dressings over free muscle flaps to the lower extremity, and shows that this technique does not compromise flap survival.

No potential conflict of interest relevant to this article was reported.

**PATIENT CONSENT**

The patient provided written informed consent for the publication and the use of their images.

![Measurement of flap thickness\
Measurement of flap thickness was performed between the skin edge and the highest and thickness point of the flap. In this case, the skin edge is at 10 mm on the ruler and highest point of the flap at 21 mm, hence the flap thickness was recorded as 11 mm.](aps-2016-01977f1){#f1-aps-2016-01977}

![Comparison between flaps with VAC and open dressings\
Comparison between flaps with VAC and open dressings in the foot treated with immediate postoperative VAC dressing (Group 1; A--C) and wet to dry dressings (Group 2; D--F). Free latissimus dorsi flap to left foot (Group 1) at postoperative day 7 (A), 21 (B) and 4 months (C). Flap is not bulky after VAC dressing is taken down and has achieved its final thickness at 4 months postoperative. Free serratus anterior flap to left foot (Group 2) at postoperative day 14 (D), 1 month (E) and 8 months (F). Flap remains bulky in the immediate postoperative period and does not atrophy until 8 months postoperatively. VAC, vacuum assisted closure dressing.](aps-2016-01977f2){#f2-aps-2016-01977}

![Comparison between flaps with VAC and open dressings\
Comparison between flaps with VAC and open dressings in the leg in the immediate postoperative period treated with VAC dressing (Group 1; A, B) and wet to dry dressings (Group 2; C, D). Group 1, free latissimus dorsi flaps in 2 different patients at postoperative day 6 for coverage of large anterior and medial leg wounds (A, B); Group 2, free latissimus dorsi flap at postoperative day 6 for coverage of anterior leg wound (C); free rectus flap at postoperative day 7 for coverage of anterior leg wound (D). Marked swelling is seen for the flaps in Group 2, but not in Group 1, where the flaps are almost even in thickness with the adjacent skin. VAC, vacuum assisted closure dressing.](aps-2016-01977f3){#f3-aps-2016-01977}

![Evolution of flap over time\
Evolution of flap appearance and thickness over time in a patient with free latissimus dorsi flap and immediate application of a VAC dressing for coverage of distal third medial leg wound. (A) Immediate postoperative, (B) postoperative day 9, (C) 6 months postoperative. Postoperative flap swelling encountered routinely with muscle flaps is not seen. The thickness of the flap remains similar on short and long-term follow-up. VAC, vacuum assisted closure dressing.](aps-2016-01977f4){#f4-aps-2016-01977}

###### 

Patient data

  Case         Age (yr)   Sex      BMI (kg/m^2^)   Location of defect   Reason for flap                    Flap size (cm^2^)   Recipient vessel   Type of arterial anastomosis   VAC (Y/N)
  ------------ ---------- -------- --------------- -------------------- ---------------------------------- ------------------- ------------------ ------------------------------ -----------
  1            29         Male     31.5            Foot                 Open 1st metatarsal fracture       Latissimus          240                PT                             ETE
  2            25         Male     27.2            Leg                  Trauma/Gustilo 3B tibia fracture   Latissimus          294                AT                             ETE
  3            40         Female   33.1            Foot                 Recurrent plantar fibromatosis     Serratus            100                PT                             ETE
  4            56         Male     27              Leg                  Trauma/Gustilo 3B tibia fracture   Latissimus          184                AT                             ETS
  5            49         Male     28.3            Leg                  Trauma/Gustilo 3B tibia fracture   Latissimus          144                PT                             ETS
  6            53         Female   22.9            Leg                  Trauma/Gustilo 3B tibia fracture   Latissimus          112                PT                             ETS
  7            53         Female   38.3            Heel                 Chronic osteomyelitis              Latissimus          144                PT                             ETE
  8            34         Male     26              Leg                  Trauma/Gustilo 3B tibia fracture   Latissimus          300                PT                             ETE
  9            19         Female   18.1            Leg                  Trauma/Gustilo 3B tibia fracture   Latissimus          161                PT                             ETE
  10           58         Male     25.4            Leg                  Trauma Gustilo 3B tibia fracture   Latissimus          198                PT                             ETE
  11           46         Male     36.2            Leg                  Chronic osteomyelitis              Gracilis            200                PT                             ETE
  Latissimus   350        AT       ETE                                                                                                                                           
  12           23         Male     25.2            Leg                  Trauma/Gustilo 3B tibia fracture   Latissimus          140                PT                             ETE
  13           18         Male     21.9            Leg                  Trauma/Gustilo 3B tibia fracture   Latissimus          350                PT                             ETE
  14           25         Male     32.2            Leg                  Trauma/Gustilo 3B tibia fracture   Rectus              225                AT                             ETE
  15           20         Female   33.3            Leg                  Trauma/Gustilo 3B tibia fracture   Rectus              300                PT                             ETE
  16           63         Male     29.2            Leg                  Trauma/Gustilo 3B tibia fracture   Rectus              300                Popliteal artery               ETS

BMI, body mass index; VAC, vacuum assisted closure dressing; PT, posterior tibial artery; ETE, end-to-end anastomosis; AT, anterior tibial artery; ETS, end-to-side anastomosis.

###### 

Flap outcome data

  Case   VAC   Flap thickness POD5 (mm)   Flap thickness (late, mm)   Flap loss   Outcome
  ------ ----- -------------------------- --------------------------- ----------- -------------------------------------------------
  1      Y     20                         20 (2 mo); 0 (15 mo)        N           Uncomplicated
  2      Y     6                          6 (20 day); 1 (74 day)      N           Uncomplicated
  3      N     40                         35 (35 day)                 N           Uncomplicated
  4      Y     2                          2 (16 day)                  N           Uncomplicated
  5      Y     3                                                      N           Uncomplicated
  6      Y     0                          0 (10 day)                  Y           Integra/split thickness skin graft/limb salvage
  7      Y     11                         10 (8 day)                  N           Uncomplicated
  8      N     15                                                     N           Uncomplicated
  9      Y     2                          2 (10 day)                  N           Uncomplicated
  10     Y     3                          3 (10 day)                  N           Uncomplicated
  11     N     45                                                     Y           Repeat flap/limb salvage
  12     Y     11                         6 (21 day)                  N           Uncomplicated
  13     N     12                                                     N           Uncomplicated
  14     N     35                                                     N           Uncomplicated
  15     N     20                                                     N           Uncomplicated
  16     N     40                                                     Y           Below knee amputation

VAC, vacuum assisted closure dressing; POD, postoperative day; Y, yes; N, no.
